Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network

MLA

Moreau, P., et al. Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: A Consensus Statement from The European Myeloma Network. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1143371300&authtype=sso&custid=ns315887.

APA

Moreau, P., Sonneveld, P. (Pieter), Boccadoro, M. (Mario), Cook, G. (Gordon), Mateos, M. V., Nahi, H. (Hareth), Goldschmidt, H. (Hartmut), Dimopoulos, M. A. (Meletios), Lucio, P. (Paulo), Bladé, J. (Joan), Delforge, M. (Michel), Hàjek, R. (Roman), Ludwig, H. (Heinz), Facon, T. (Thierry), San Miguel, J. F. (Jesús F., & Einsele, H. (2019). Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network.

Chicago

Moreau, P., P. (Pieter) Sonneveld, M. (Mario) Boccadoro, G. (Gordon) Cook, M.V. Mateos, H. (Hareth) Nahi, H. (Hartmut) Goldschmidt, et al. 2019. “Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: A Consensus Statement from The European Myeloma Network.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1143371300&authtype=sso&custid=ns315887.